• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连花清瘟胶囊对急性肺损伤动物模型巨噬细胞趋化作用的疗效及机制研究

[Efficacy and mechanism of Lianhua Qingwen Capsules(LHQW) on chemotaxis of macrophages in acute lung injury (ALI) animal model].

作者信息

Li Qi, Yin Jie, Ran Qing-Sen, Yang Qing, Liu Li, Zhao Zheng, Li Yu-Jie, Chen Ying, Sun Li-Dong, Wang Ya-Jie, Weng Xiao-Gang, Cai Wei-Yan, Zhu Xiao-Xin

机构信息

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China School of Chinese Materia Medica, Capital Medical University Beijing 100069, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2019 Jun;44(11):2317-2323. doi: 10.19540/j.cnki.cjcmm.20190210.001.

DOI:10.19540/j.cnki.cjcmm.20190210.001
PMID:31359658
Abstract

This paper was mainly to discuss the potential role and mechanism of Lianhua Qingwen Capsules(LHQW) in inhibiting pathological inflammation in the model of acute lung injury caused by bacterial infection. For in vitro study, the mRNA expression of MCP-1 in RAW264.7 cells and THP-1 cells, the content of MCP-1 in cell supernatant, as well as the effect of LHQW on chemotaxis of macrophages were detected. For in vivo study, mice were randomly divided into 7 groups, including normal group, model group(LPS 5 mg·kg(-1)), LHQW 300, 600 and 1 200 mg·kg(-1)(low, middle and high dose) groups, dexamethasone 5 mg·kg~(-1) group and penicillin-streptomycin group. Then, the anal temperature was detected two hours later. Dry weight and wet weight of lung tissues in mice were determined; TNF-α and MCP-1 levels in alveolar lavage fluid and MCP-1 in serum were detected. In addition, the infiltration of alveolar macrophages was also observed and the infiltration count of alveolar macrophages was measured by CCK-8 method. HE staining was also used to observe the inflammatory infiltration of lung tissues in mice. Both of the in vitro and in vivo data consistently have confirmed that: by down-regulating the expression of MCP-1, LHWQ could efficiently decrease the chemotaxis of monocytes toward the pulmonary infection foci, thus blocking the disease development in ALI animal model.

摘要

本文主要探讨连花清瘟胶囊(LHQW)在抑制细菌感染所致急性肺损伤模型中病理性炎症的潜在作用及机制。体外研究检测RAW264.7细胞和THP-1细胞中MCP-1的mRNA表达、细胞上清液中MCP-1的含量以及LHQW对巨噬细胞趋化性的影响。体内研究将小鼠随机分为7组,包括正常组、模型组(LPS 5 mg·kg⁻¹)、LHQW 300、600和1200 mg·kg⁻¹(低、中、高剂量)组、地塞米松5 mg·kg⁻¹组和青霉素-链霉素组。两小时后检测肛温,测定小鼠肺组织干重和湿重,检测肺泡灌洗液中TNF-α和MCP-1水平以及血清中MCP-1水平。此外,观察肺泡巨噬细胞浸润情况并采用CCK-8法测定肺泡巨噬细胞浸润计数,还用HE染色观察小鼠肺组织的炎性浸润。体外和体内数据均一致证实:通过下调MCP-1的表达,LHWQ可有效降低单核细胞向肺部感染灶的趋化性,从而阻断ALI动物模型中的疾病发展。

相似文献

1
[Efficacy and mechanism of Lianhua Qingwen Capsules(LHQW) on chemotaxis of macrophages in acute lung injury (ALI) animal model].连花清瘟胶囊对急性肺损伤动物模型巨噬细胞趋化作用的疗效及机制研究
Zhongguo Zhong Yao Za Zhi. 2019 Jun;44(11):2317-2323. doi: 10.19540/j.cnki.cjcmm.20190210.001.
2
Lianhua Qingwen protects LPS-induced acute lung injury by promoting M2 macrophage infiltration.连花清瘟通过促进 M2 巨噬细胞浸润来保护 LPS 诱导的急性肺损伤。
J Ethnopharmacol. 2024 Feb 10;320:117467. doi: 10.1016/j.jep.2023.117467. Epub 2023 Nov 18.
3
Anti-inflammatory effects and mechanism of the total flavonoids from Artemisia scoparia Waldst. et kit. in vitro and in vivo.黄花蒿总黄酮的体内外抗炎作用及其机制。
Biomed Pharmacother. 2018 Aug;104:390-403. doi: 10.1016/j.biopha.2018.05.054. Epub 2018 May 25.
4
Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release.橙皮苷通过抑制高迁移率族蛋白B1的释放改善脂多糖诱导的小鼠急性肺损伤。
Int Immunopharmacol. 2015 Apr;25(2):370-6. doi: 10.1016/j.intimp.2015.02.022. Epub 2015 Feb 25.
5
Mechanisms Underlying the Effects of Lianhua Qingwen on Sepsis-Induced Acute Lung Injury: A Network Pharmacology Approach.连花清瘟对脓毒症诱导的急性肺损伤影响的潜在机制:一种网络药理学方法
Front Pharmacol. 2021 Oct 14;12:717652. doi: 10.3389/fphar.2021.717652. eCollection 2021.
6
Effects of Lianhua Qingwen on Pulmonary Oxidative Lesions Induced by Fine Particulates (PM2.5) in Rats.连花清瘟对大鼠细颗粒物(PM2.5)诱导的肺氧化损伤的影响
Chin Med Sci J. 2016 Nov 20;31(4):233-8. doi: 10.1016/s1001-9294(17)30006-8.
7
Lian Hua Qing Wen Capsules, a Potent Epithelial Protector in Acute Lung Injury Model, Block Proapoptotic Communication Between Macrophages, and Alveolar Epithelial Cells.连花清瘟胶囊,急性肺损伤模型中的强效上皮保护剂,可阻断巨噬细胞与肺泡上皮细胞之间的促凋亡信号传递。
Front Pharmacol. 2020 Sep 23;11:522729. doi: 10.3389/fphar.2020.522729. eCollection 2020.
8
[The effect of recombinant interleukin-10/Fc fusion protein on lipopolysaccharide-induced acute lung injury in mice].重组白细胞介素-10/Fc融合蛋白对脂多糖诱导的小鼠急性肺损伤的影响
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 Aug;20(8):461-4.
9
Rhesus θ-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment.恒河猴 θ-防御素-1 通过抑制促炎细胞因子和中性粒细胞募集来减轻内毒素诱导的急性肺损伤。
Am J Respir Cell Mol Biol. 2018 Mar;58(3):310-319. doi: 10.1165/rcmb.2016-0428OC.
10
Alleviates Lipopolysaccharide-Induced Acute Lung Injury via Suppression of Proinflammatory Mediators and Downregulation of the NF-B Signaling Pathway.通过抑制促炎介质和下调NF-κB信号通路减轻脂多糖诱导的急性肺损伤。
Mediators Inflamm. 2016;2016:7934049. doi: 10.1155/2016/7934049. Epub 2016 Nov 6.

引用本文的文献

1
Molecular mechanism of honeysuckle + forsythia in treatment of acute lung injury based on network pharmacology.基于网络药理学的金银花 + 连翘治疗急性肺损伤的分子机制
Biomed Rep. 2024 Jan 3;20(2):32. doi: 10.3892/br.2024.1720. eCollection 2024 Feb.
2
Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019.关于连花清瘟联合西药治疗 2019 冠状病毒病的疗效的 Meta 分析。
J Integr Med. 2022 Jan;20(1):26-33. doi: 10.1016/j.joim.2021.10.005. Epub 2021 Nov 2.
3
Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review.
治疗新冠肺炎的中成药作用机制综述
Front Pharmacol. 2021 Jul 15;12:668407. doi: 10.3389/fphar.2021.668407. eCollection 2021.
4
Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects.连花清瘟治疗 2019 冠状病毒病(COVID-19)的处方:进展与展望。
Biomed Pharmacother. 2020 Oct;130:110641. doi: 10.1016/j.biopha.2020.110641. Epub 2020 Aug 19.
5
Efficacy and safety of Lianhuaqingwen for mild or moderate coronavirus disease 2019: A meta-analysis of randomized controlled trials.连花清瘟治疗轻中度 2019 冠状病毒病的疗效和安全性:一项随机对照试验的荟萃分析。
Medicine (Baltimore). 2021 May 28;100(21):e26059. doi: 10.1097/MD.0000000000026059.
6
Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen).建立基于抗炎的生物测定法,用于控制 13 种成分的中药配方(连花清瘟)的质量。
Pharm Biol. 2021 Dec;59(1):537-545. doi: 10.1080/13880209.2021.1917627.
7
Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening.基于人体暴露和ACE2生物色谱筛选鉴定中药连花清瘟胶囊潜在的抗COVID-19药理成分
Acta Pharm Sin B. 2021 Jan;11(1):222-236. doi: 10.1016/j.apsb.2020.10.002. Epub 2020 Oct 10.
8
Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.天然产物衍生的植物化学物质通过多种机制管理急性肺损伤。
Pharmacol Res. 2021 Jan;163:105224. doi: 10.1016/j.phrs.2020.105224. Epub 2020 Sep 29.
9
Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China.中成药在中国治疗新型冠状病毒肺炎(COVID-19)中的应用
Front Pharmacol. 2020 Jul 17;11:1066. doi: 10.3389/fphar.2020.01066. eCollection 2020.
10
Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community.抗击新冠疫情:早期检测、医疗救治与全球社会的共同努力
Research (Wash D C). 2020 Jun 16;2020:6925296. doi: 10.34133/2020/6925296. eCollection 2020.